|
End-of-day quote
Shenzhen S.E.
2026-10-30
|
5-day change | 1st Jan Change | ||
| 37.65 CNY | -3.63% |
|
-5.99% | +28.50% |
| Market Cap | 4.08B 613M 549M 505M 457M 855M 58.16B 871M 6.02B 2.42B 30.6B 2.3B 2.25B 96.49B | P/E 2024 |
53.4x | P/E 2025 | 195x |
|---|---|---|---|---|---|
| Enterprise Value | 3.83B 575M 515M 474M 430M 803M 54.64B 818M 5.65B 2.27B 28.74B 2.16B 2.11B 90.65B | EV / Sales 2024 |
6.15x | EV / Sales 2025 | 7.35x |
| Free-Float |
42.36% | Yield 2024 |
0.67% | Yield 2025 | 0.17% |
| 1 day | -3.63% | ||
| 1 week | -5.99% | ||
| 1 month | -20.32% | ||
| 3 months | +11.56% | ||
| 6 months | -0.11% | ||
| Current year | +28.50% |
| 1 week | 37.4 |  | 41.8 |
| 1 month | 36.66 | | 49.5 |
| Current year | 28.3 | | 59.24 |
| 1 year | 25.87 | | 59.24 |
| 3 years | 18.52 | | 59.24 |
| 5 years | 18.52 | | 63.99 |
| 10 years | 18.52 | | 63.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Guo Wei
PSD | President | 47 | 2026-03-11 |
Yan Bing Li
DFI | Director of Finance/CFO | 44 | 2026-03-11 |
Gong Yuan Chang
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Xiao Hong Zou
BRD | Director/Board Member | 67 | 2015-09-05 |
Bin Wu
BRD | Director/Board Member | 66 | 2023-11-09 |
Hong Fu Li
CHM | Chairman | 41 | 2025-11-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.63% | -5.99% | +18.25% | -0.74% | 613M | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.51% | +4.49% | +43.75% | +76.03% | 426.25B | |
| Weighted average by Cap. | +2.01% | +6.60% | +50.50% | +100.42% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 464M 69.67M 62.4M 57.4M 52.01M 97.21M 6.62B 99.03M 684M 275M 3.48B 261M 256M 10.97B | 398M 59.83M 53.59M 49.29M 44.66M 83.48M 5.68B 85.04M 588M 236M 2.99B 225M 220M 9.42B |
| Net income | 60.27M 9.06M 8.11M 7.46M 6.76M 12.64M 860M 12.87M 88.96M 35.71M 452M 33.98M 33.26M 1.43B | 16.55M 2.49M 2.23M 2.05M 1.86M 3.47M 236M 3.54M 24.43M 9.81M 124M 9.33M 9.14M 392M |
| Net Debt | -387M -58.13M -52.06M -47.89M -43.39M -81.11M -5.52B -82.63M -571M -229M -2.9B -218M -214M -9.16B | -247M -37.07M -33.2M -30.54M -27.67M -51.72M -3.52B -52.69M -364M -146M -1.85B -139M -136M -5.84B |
Employees
650
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | CN¥37.65 | -3.63% | 1,482,630 |
| 26-10-29 | CN¥39.07 | -4.36% | 1,199,630 |
| 26-10-28 | CN¥40.85 | +3.73% | 1,873,916 |
| 26-10-27 | CN¥39.38 | -3.95% | 2,064,500 |
| 26-10-26 | CN¥41.00 | +2.37% | 2,771,608 |
- Stock Market
- Stocks
- 301281 Stock
Select your edition
All financial news and data tailored to specific country editions
